Drugs Made In Amer Acq Ii Stock Price, News & Analysis
Company Description
Drugs Made In Amer Acq Ii (NASDAQ: DMII) is a publicly traded shell companies company in the Blank Checks sector. The company has a market capitalization of $637.6M, ranking #3,313 among all listed U.S. companies by market cap.
DMII stock has gained 1.4% over the past year, placing it at #2,341 in year-to-date performance among tracked companies. Shares last traded at $10.02.
On a trailing twelve-month basis, Drugs Made In Amer Acq Ii reported net income of $4.2M.
This page provides a comprehensive overview of DMII stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Drugs Made In Amer Acq Ii (DMII) stock last traded at $10.02, down 0.05% from the previous close. Over the past 12 months, the stock has gained 1.4%. At a market capitalization of $637.6M, DMII is classified as a small-cap stock with approximately 63.7M shares outstanding.
DMII Rankings
Latest News
SEC Filings
Drugs Made In Amer Acq Ii has filed 5 recent SEC filings, including 3 Form 8-K, 1 Form 10-K, 1 Form NT 10-K. The most recent filing was submitted on April 28, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all DMII SEC filings →
Financial Highlights
operating income reached -$488K, and net income was $4.2M. The company generated -$1.0M in operating cash flow. With a current ratio of 0.09, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Drugs Made In Amer Acq Ii (DMII) currently stands at 40.3 thousand shares, down 1.7% from the previous reporting period, representing 0.1% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Drugs Made In Amer Acq Ii (DMII) currently stands at 1.4 days, up 36% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 36% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 8.8 days.
DMII Company Profile & Sector Positioning
Drugs Made In Amer Acq Ii (DMII) operates in the Shell Companies industry within the broader Blank Checks sector and is listed on the NASDAQ. In monthly performance, the stock ranks #4,142 among all tracked companies.